I have to pick apart your post, because there are

I have to pick apart your post, because there are a few sweeping generalizations and comparisons that don’t really apply.

If a ceo leads a company from $10 to less than $1 share price, sure they should get replaced. However, when you realize the run up to$10 was part of a pump and dump, using that as a measure is not applicable. Also, this is a pre revenue company, a $9 fall in stock price is not a fundamental fall, it’s not a margin compression and it is not a lost business problem. It is a speculation problem. Nader can’t be responsible if investors jump on a spike in stock price, the investors are responsible for that. He was running the company the same way at $.30 as he was at any other price.

Buyouts and partnerships are nice, but not if they are for Pennie’s on the dollar. If that is all you are getting you focus on what we all think this is worth and not what some third party fails to see. This is what Cytodyn has done and I would be absolutely be pissed if we sold for $1-2 per share.

I think Nader is very well aware of the current share price and I am sure his email is packed with pissed investors comments on it. He has a challenge that could have been possible avoided. I don’t know how to overcome the current situation quickly. One thing for sure, continuing forward with trails and data is obviously the thing we can do, which is what they are doing.